US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes

It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.

corona stimulus

The OTC drug industry has lobbied to rescind a requirement that US consumers need a prescription to use pre-tax savings accounts to buy OTC drugs since it was imposed in 2011.

And the industry has looked for a legislative vehicle to modernize and streamline the Food and Drug Administration’s OTC drug monograph program since agreeing with

It’s unlikely that any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, businesses and health care providers and facilities in response to a pandemic, including extensive support opportunities for small

More from United States

More from North America